Design, Optimization and Evaluation of Fast-Dissolving Oral Films of Ropinirole

DOI:

https://doi.org/10.37285/ijpsn.2018.11.1.3

Authors

  • Bhikshapathi D. V. R. N.
  • Srinivas A

Abstract

The main objective of this study was to develop fast dissolving oral films of ropinirole HCl to attain quick onset of action for the better management of Parkinson’s disease. Twenty-seven formulations (F1-F27) of ropinirole oral dissolving films by solvent-casting method using 33 response surface method by using HPMC E15, Maltodextrin PEG 4000 by using Design of experiment software. Formulations were evaluated for their physical characteristics, thickness, folding endurance, tensile strength, disintegration time, drug content uniformity and drug release characteristics and found to be within the limits. Among the prepared formulations F4 showed minimum disintegration time 11 sec, maximum drug was released i.e. 99.68 ± 1.52% of drug within 10 min when compared to the other formulations and finalized as optimized formulation. FTIR data revealed that no interactions takes place between the drug and polymers used in the optimized formulation. The in vitro dissolution profiles of marketed product and optimized formulation was compared and found to be the drug released was 92.77 ± 1.52 after 50 min. Therefore, it can be a good alternative to conventional ropinirole for immediate action. In vitro evaluation of the ropinirole fast dissolving films confirmed their potential as an innovative dosage form to improve delivery and quick onset of action of ropinirole. The oral dissolving film is considered to be potentially useful for the treatment of Parkinson’s disease where quick onset of action is desired

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Ropinirole, Parkinson’s disease, Oral films, disintegration time, HPMC

Downloads

Published

2018-01-31

How to Cite

1.
D. V. R. N. B, A S. Design, Optimization and Evaluation of Fast-Dissolving Oral Films of Ropinirole. Scopus Indexed [Internet]. 2018 Jan. 31 [cited 2024 Nov. 19];11(1):3958-67. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/348

Issue

Section

Research Articles

References

Amit K, Jain Parridhi and Baviskar Rowe Dheeraj (2009). Development of buccal patch containing aceclofenac: in vitro evaluation. Int J Pharm 1(4): 34-42.
Bagul U, Kishore Gujar, Nancy Patel, Sanjeevani Aphale, and Shalaka Dhat (2010). Formulation and evaluation of Sublimed Fast Melt Tablets of Levocetirizine Dihydrochloride. Int J Pharm Sci 2:76-80.
Bhupinder B, Sarita J, Mandeep K and Harmanpreet S (2011). Orally fast dissolving films: innovations in formulations and technology. Int J Pharm Sci Rev Res 9(2): 50-7.
Borsadia S, Halloran D, Osborne JL (2003). Quick dissolving films-A novel approach to drug delivery. Drug Deliv Technol 3: 63-6.
Debra TJ (2007). Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease, Clinical Pharmacokinetics 29 (12): 2654-66.
El-Setouhy DA and Nevine Shawky Abd El-Malak (2010). Formulation of a novel tianeptine sodium orodispersible film. AAPS Pharm Sci Tech 11: 1018-025.
Fule R and Amin P (2014). Development and evaluation of Lafutidine solid dispersion via hot melt extrusion: Investigating drug-polymer miscibility with advanced characterization. Asian Journal of Pharmaceutical Sciences 9(2): 92-106.
Hornykiewicz O (1963). Advances in Neurology 60: 140-147.
Klancke J (2003). Dissolution testing of orally disintegrating tablets. Dissolut Technol 10: 6-8.
Koland M, Sandeep VP and Charyulu NR (2010). Fast Dissolving Sublingual Films of Ondansetron Hydrochloride: Effect of Additives on in vitro Drug Release and Mucosal Permeation. J Young Pharm 2(3): 216-22.
Kumar GV, Krishna RV, William GJ and Konde A (2005). Formulation and evaluation of buccal films of salbutamol sulphate. Indian J Pharm Sci 67:160-4.
Liang AC and Chen LH (2001). Fast-dissolving intraoral drug delivery systems. Exp Opin Ther Patents 11: 981-6.
Mashru R.C, Sutariya BC, and Parikh PP (2005). Development and evaluation of fast dissolving films of Salbutamol sulphate. Drug Dev Ind Pharm 35: 25-34.
Montgomery DC (2005). Design and Analysis of Experiments: Response surface method and designs, John Wiley and Sons, Inc. New Jersey, 210-256.
Parakh SR and Gothoskar AV (2003). Review of oral dissolving tablet technologies. Pharm Tech 27: 92-100.
Prabhu P, Ravi Malli, Marina Koland, K Vijaynarayana, Ullas D’Souza, Harish NM, CS Shastri and RN Charyulu (2011). Formulation and evaluation of fast dissolving films of levocitirizine dihydrochloride. Int J Pharm Inv 1(2): 99-104.
Rahul N, Sevukarajan.M, Vishnu Priya K, and Arun Kumar K.S (2015). Response Surface Methodology for the Optimization OF Ethylcellulose Microspheres. International Journal of PharmTech Research 3(2): 775-783.
Rajni Bala, Pravin Pawar, Sushil Khanna, and Sandeep Arora (2013). Orally dissolving strips: A new approach to oral drug delivery system. Int J Pharm Investig 3(2): 67-76
Rawas-Qalaji MM, Simons FE, and Simons KJ (2006). Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics. AAPS Pharm Sci Tech 7: 1-7.
Revathi V (2007). Fast Dissolving drug delivery system. Pharma Times 39: 22-3.
Salman ZD, Nidhal Maraie K, Mustafa Alabbassi G, and Mowafaq Ghareeb M (2014). In Vitro/In Vivo Evaluation and Bioavailability Study of Amitriptyline Hydrochloride from the Optimized Oral Fast Dissolving Films. UK Journal of Pharmaceutical and Biosciences 2(6): 32-42.
Schwartz BJ and Connor RE (1996). Optimization technique in pharmaceutical formulations and processing. J Drugs Pharm Sci Modern Pharm 72: 727-54.
Swapnil LP, Paresh RM, Madhavi AS, Shradha ST, Ketan VP, and Prashant NS (2012). Fast dissolving oral films: an innovative drug delivery system. Int J Res Rev Pharm Appl Sci 2(3): 482-96.

Most read articles by the same author(s)

1 2 > >>